Abstract

We welcome Béranger et al.'s response to our recent publication (1), and we agree that the effect of continuous renal replacement therapy (CRRT) on pharmacokinetic parameters for meropenem (MEM) should be discussed. As Béranger et al. pointed out, extracorporeal membrane oxygenation (ECMO) was probably a component of the CRRT covariate, and it may have contributed to the increase in central volume of distribution. In fact, the circuit priming volume for ECMO can be several times higher than the pediatric patient's blood volume, and hemodilution effect is inversely related to age (2).….

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.